MGO One Seven’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Buy |
41,365
+65
| +0.2% | +$846 | 0.02% | 688 |
|
|
2025
Q1 | $437K | Sell |
41,300
-50
| -0.1% | -$530 | 0.02% | 672 |
|
|
2024
Q4 | $702K | Buy |
41,350
+2,204
| +6% | +$37.4K | 0.03% | 534 |
|
|
2024
Q3 | $909K | Buy |
39,146
+15,733
| +67% | +$365K | 0.04% | 424 |
|
|
2024
Q2 | $570K | Buy |
23,413
+1,925
| +9% | +$46.9K | 0.03% | 514 |
|
|
2024
Q1 | $726K | Sell |
21,488
-3,000
| -12% | -$101K | 0.04% | 420 |
|
|
2023
Q4 | $772K | Buy |
24,488
+800
| +3% | +$25.2K | 0.04% | 381 |
|
|
2023
Q3 | $605K | Buy |
23,688
+1,000
| +4% | +$25.6K | 0.05% | 372 |
|
|
2023
Q2 | $651K | Buy |
22,688
+900
| +4% | +$25.8K | 0.06% | 346 |
|
|
2023
Q1 | $522K | Sell |
21,788
-3,000
| -12% | -$71.9K | 0.03% | 464 |
|
|
2022
Q4 | $420K | Sell |
24,788
-5,425
| -18% | -$92K | 0.04% | 449 |
|
|
2022
Q3 | $447 | Buy |
30,213
+1,500
| +5% | +$22 | 0.02% | 414 |
|
|
2022
Q2 | $452K | Sell |
28,713
-200
| -0.7% | -$3.15K | 0.06% | 349 |
|
|
2022
Q1 | $779K | Hold |
28,913
| – | – | 0.08% | 258 |
|
|
2021
Q4 | $1.07M | Sell |
28,913
-89
| -0.3% | -$3.29K | 0.11% | 218 |
|
|
2021
Q3 | $1.3M | Sell |
29,002
-1,214
| -4% | -$54.6K | 0.17% | 157 |
|
|
2021
Q2 | $1.02M | Buy |
30,216
+3,226
| +12% | +$109K | 0.14% | 176 |
|
|
2021
Q1 | $1.11M | Buy |
26,990
+3,197
| +13% | +$132K | 0.19% | 134 |
|
|
2020
Q4 | $1.03M | Sell |
23,793
-68
| -0.3% | -$2.95K | 0.21% | 122 |
|
|
2020
Q3 | $1.02M | Buy |
23,861
+2,761
| +13% | +$118K | 0.24% | 101 |
|
|
2020
Q2 | $986K | Buy |
21,100
+1,450
| +7% | +$67.8K | 0.26% | 105 |
|
|
2020
Q1 | $267K | Buy |
19,650
+4,750
| +32% | +$64.5K | 0.09% | 299 |
|
|
2019
Q4 | $161K | Buy |
14,900
+200
| +1% | +$2.16K | 0.04% | 417 |
|
|
2019
Q3 | $151K | Buy |
+14,700
| New | +$151K | 0.04% | 414 |
|